Skin Metastasis of Gastrointestinal Stromal Tumors: A Case Series and Literature Review

被引:4
作者
Liu, Peng [1 ]
Tan, Fengbo [1 ]
Liu, Heli [1 ]
Ge, Jie [1 ]
Liu, Sheng [1 ]
Lei, Tianxiang [1 ]
Zhao, Xianhui [1 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Gastrointestinal Surg, Changsha 410008, Hunan, Peoples R China
来源
CANCER MANAGEMENT AND RESEARCH | 2020年 / 12卷
关键词
gastrointestinal stromal tumor; skin metastasis; tyrosine kinase inhibitors; SUBCUTANEOUS METASTASIS; IMATINIB MESYLATE; CUTANEOUS METASTASES; TYROSINE KINASE; FREE SURVIVAL; KIT; MUTATIONS; THERAPY; STOMACH; RECURRENCE;
D O I
10.2147/CMAR.S261823
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Gastrointestinal stromal tumors (GISTs) extremely and rarely metastasize to the skin, and such metastases have not been well characterized. Methods: Retrospective analysis of clinicopathological data of patients with skin metastasis of a GIST (SM-GIST) admitted to Xiangya Hospital (Changsha, Hunan, China) and literature review were conducted. Results: Including our 4 cases, a total of 17 cases have been reported to date. The mean age of the patients was 55.4 years (2970 years) and there was not sex predominance (male 10 and female 7). Primary tumors were often located in the stomach (n=9), duodenum (n=2) and small bowel (n=2). Meanwhile, SM-GIST mainly occurred in head and face (n=6), extremities (n=6), followed by abdomen wall (n=5), back (n=3) and chest (n=2). Mutation analysis revealed that the frequency of wild-type GIST (WT-GIST), exon 9, 11 and 13 mutations was 6, 1, 4 and 1, respectively. The average time to SM-GIST was 4.22 years, specifically 4.59 years in gastric and 3.8 years in non-gastric. Moreover, for the resection only group (including chemotherapy), such average time was 3.63 years, while for the combined group (resection and tyrosine kinase inhibitors (TKIs)), it was about 4.74 years. The mean survival was approximately 6.2 years. However, after the diagnosis of SM-GIST, survival was only about 1.69 years. Conclusion: SM-GIST is a rare malignant condition. Non-gastric GIST, surgery without TKIs, high invasiveness and tumor burden, and molecular subtype (mutation in exon 9, 11 and wild-type) may be conducive to the development of SM-GIST. Additionally, it is also a sign of poor prognosis.
引用
收藏
页码:7681 / 7690
页数:10
相关论文
共 44 条
  • [1] Multidrug resistant gastrointestinal stromal tumor with multiple metastases to the skin and subcutaneous soft tissue: A case report and review of literature
    Aickara, Divya J.
    McBride, Jeffrey
    Morrison, Brian
    Romanelli, Paolo
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 2020, 47 (04) : 398 - 401
  • [2] Anagnostoulis S, 2007, J BUON, V12, P549
  • [3] Antonescu CR, 2003, CLIN CANCER RES, V9, P3329
  • [4] Dedifferentiation in Gastrointestinal Stromal Tumor to an Anaplastic KIT-negative Phenotype: A Diagnostic Pitfall Morphologic and Molecular Characterization of 8 Cases Occurring Either De Novo or After Imatinib Therapy
    Antonescu, Cristina R.
    Romeo, Salvatore
    Zhang, Lei
    Nafa, Khedoudja
    Hornick, Jason L.
    Nielsen, Gunnlaugur Petur
    Mino-Kenudson, Mari
    Huang, Hsuan-Ying
    Mosquera, Juan-Miguel
    Dei Tos, Paolo A.
    Fletcher, Christopher D. M.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2013, 37 (03) : 385 - 392
  • [5] Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033
    Blanke, Charles D.
    Rankin, Cathryn
    Demetri, George D.
    Ryan, Christopher W.
    von Mehren, Margaret
    Benjamin, Robert S.
    Raymond, A. Kevin
    Bramwell, Vivien H. C.
    Baker, Laurence H.
    Maki, Robert G.
    Tanaka, Michael
    Hecht, J. Randolph
    Heinrich, Michael C.
    Fletcher, Christopher D. M.
    Crowley, John J.
    Borden, Ernest C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) : 626 - 632
  • [6] Malignant gastrointestinal stromal tumor: Distribution, imaging features, and pattern of metastatic spread
    Burkill, GJC
    Badran, M
    Al-Muderis, O
    Thomas, JM
    Judson, IR
    Fisher, C
    Moskovic, EC
    [J]. RADIOLOGY, 2003, 226 (02) : 527 - 532
  • [7] Dedifferentiated gastrointestinal stromal tumor arising de novo from the small intestine
    Choi, Jacqueline J.
    Sinada-Bottros, Laura
    Maker, Ajay V.
    Weisenberg, Elliot
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2014, 210 (04) : 264 - 266
  • [8] Gastrointestinal stromal tumours: origin and molecular oncology
    Corless, Christopher L.
    Barnett, Christine M.
    Heinrich, Michael C.
    [J]. NATURE REVIEWS CANCER, 2011, 11 (12) : 865 - 878
  • [9] Biology of gastrointestinal stromal tumors
    Corless, CL
    Fletcher, JA
    Heinrich, MC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (18) : 3813 - 3825
  • [10] Demetri GD, 2010, J NATL COMPR CANC NE, V8, pS1